PMCB logo

PharmaCyte Biotech (PMCB) Selling, General & Administrative Expenses

Annual SGA

$4.79 M
+$38.20 K+0.80%

April 30, 2024

Summary

Performance

1-Year Change

+0.8%

3-Year Change

+274.94%

5-Year Change

+129.71%

15-Year Change

+271.62%

PMCB SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.57%
PMCB annual SGA is higher than 7.57% of companies in Healthcare sector

High & Low

All-time High

$7.75 M
PMCB annual SGA is currently -38.22% below its historical high of $7.75 million

3-Year Low

$1.28 M
PMCB annual SGA is currently +274.94% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Apr 30, 2024
PMCB previous annual earnings announcement was published on Apr 30, 2024

Next Annual Earnings Report Date

N/A
PMCB next annual earnings announcement has not yet been scheduled

OtherPMCBexpensesmetrics:

Annual Total Expenses

$6.52 M
PMCB annual total expenses is $6.52 million

Annual Operating Expenses

$6.52 M
PMCB annual total operating expenses is $6.52 million

Annual Cost Of Goods Sold

-
PMCB annual cost of goods sold value is unknown

Annual Interest Expense

-
PMCB annual interest expense value is unknown

Quarterly SGA

$725.30 K
-$58.10 K-7.42%

October 31, 2024

Summary

Performance

3-Month Change

-7.42%

1-Year Change

-33.96%

3-Year Change

-42.25%

5-Year Change

-42.25%

PMCB Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.08%
PMCB quarterly SGA is higher than 2.08% of companies in Healthcare sector

High & Low

All-time High

$5.71 M
PMCB quarterly SGA is currently -87.31% below its historical high of $5.71 million

3-Year Low

$431.00 K
PMCB quarterly SGA is currently +68.28% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
PMCB previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
PMCB next earnings announcement is scheduled for Mar 18, 2025

OtherPMCBexpensesmetrics:

Quarterly Total Expenses

$1.11 M
PMCB quarterly total expenses is $1.11 million

Quarterly Operating Expenses

$1.11 M
PMCB quarterly total operating expenses is $1.11 million

Quarterly Cost Of Goods Sold

-
PMCB quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
PMCB quarterly interest expense value is unknown

TTM SGA

-$418.47 M
+$22.68 M+5.14%

October 31, 2024

Summary

Performance

3-Month Change

-10990.09%

1-Year Change

-9104.85%

3-Year Change

-9004.26%

5-Year Change

-9004.26%

PMCB TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.16%
PMCB TTM SGA is higher than 66.16% of companies in Healthcare sector

High & Low

All-time High

-$643.30 K

3-Year Low

-$468.74 M

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
PMCB previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
PMCB next earnings announcement is scheduled for Mar 18, 2025

OtherPMCBexpensesmetrics:

Annual Total Expenses

$6.52 M
PMCB annual total expenses is $6.52 million

Annual Operating Expenses

$6.52 M
PMCB annual total operating expenses is $6.52 million

TTM Cost Of Goods Sold

-
PMCB TTM cost of goods sold value is unknown

TTM Interest Expense

-
PMCB TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$4.79 M
PMCB annual SGA is $4.79 million

Annual Operating Expenses

$6.52 M
PMCB annual total operating expenses is $6.52 million

Annual Cost Of Goods Sold

-
PMCB annual cost of goods sold value is unknown

PMCB Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.8%-34.0%-9104.9%
3 y3 years+274.9%-42.3%-9004.3%
5 y5 years+129.7%-42.3%-9004.3%

PMCB Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+274.9%-58.3%+68.3%at high+10.7%
5 y5-yearat high+274.9%-58.3%+195.2%-2.9%+10.7%
alltimeall time-38.2%>+9999.0%-87.3%+1125.9%<-9999.0%+10.7%

PharmaCyte Biotech Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Oct 2024
-
$725.30 K(-7.4%)
$3.47 M(-9.7%)
Jul 2024
-
$783.40 K(-6.7%)
$3.84 M(-19.8%)
Apr 2024
$4.79 M(+0.8%)
$839.60 K(-25.1%)
$4.79 M(+6.1%)
Jan 2024
-
$1.12 M(+2.1%)
$4.51 M(-2.9%)
Oct 2023
-
$1.10 M(-36.5%)
$4.65 M(-12.1%)
Jul 2023
-
$1.73 M(+207.9%)
$5.29 M(+11.3%)
Apr 2023
$4.75 M(+120.4%)
$562.10 K(-55.2%)
$4.75 M(+1.1%)
Jan 2023
-
$1.26 M(-27.8%)
$4.70 M(+21.3%)
Oct 2022
-
$1.74 M(+45.8%)
$3.87 M(+41.5%)
Jul 2022
-
$1.19 M(+134.1%)
$2.74 M(+27.0%)
Apr 2022
$2.16 M(+68.8%)
$509.90 K(+18.3%)
$2.16 M(+2.7%)
Jan 2022
-
$431.00 K(-28.7%)
$2.10 M(+9.6%)
Oct 2021
-
$604.60 K(-1.0%)
$1.92 M(+23.1%)
Jul 2021
-
$610.90 K(+34.9%)
$1.56 M(+21.8%)
Apr 2021
$1.28 M(-34.1%)
$453.00 K(+83.6%)
$1.28 M(+6.9%)
Jan 2021
-
$246.70 K(+0.4%)
$1.20 M(-8.4%)
Oct 2020
-
$245.70 K(-26.0%)
$1.30 M(-21.5%)
Jul 2020
-
$332.10 K(-10.5%)
$1.66 M(-14.3%)
Apr 2020
$1.94 M(-7.0%)
$371.00 K(+4.2%)
$1.94 M(-18.1%)
Jan 2020
-
$356.00 K(-41.0%)
$2.37 M(+4.9%)
Oct 2019
-
$603.00 K(-0.9%)
$2.26 M(+4.3%)
Jul 2019
-
$608.60 K(-23.8%)
$2.16 M(+3.8%)
Apr 2019
$2.09 M(-24.5%)
$798.30 K(+225.0%)
$2.09 M(+1.4%)
Jan 2019
-
$245.60 K(-51.9%)
$2.06 M(-14.4%)
Oct 2018
-
$511.00 K(-3.7%)
$2.40 M(-8.1%)
Jul 2018
-
$530.40 K(-31.0%)
$2.61 M(-5.4%)
Apr 2018
$2.76 M(+114.3%)
$769.10 K(+30.1%)
$2.76 M(+19.7%)
Jan 2018
-
$591.10 K(-18.3%)
$2.31 M(+14.2%)
Oct 2017
-
$723.30 K(+6.5%)
$2.02 M(+32.4%)
Jul 2017
-
$679.30 K(+116.4%)
$1.53 M(+18.5%)
Apr 2017
$1.29 M(-53.9%)
$313.90 K(+3.0%)
$1.29 M(-1.6%)
Jan 2017
-
$304.70 K(+33.1%)
$1.31 M(-25.5%)
Oct 2016
-
$229.00 K(-48.1%)
$1.76 M(-24.4%)
Jul 2016
-
$441.40 K(+31.6%)
$2.32 M(-16.8%)
Apr 2016
$2.79 M(-15.2%)
$335.40 K(-55.4%)
$2.79 M(+17.0%)
Jan 2016
-
$752.30 K(-5.4%)
$2.39 M(-8.7%)
Oct 2015
-
$795.60 K(-12.7%)
$2.61 M(-9.1%)
Jul 2015
-
$911.10 K(-1388.7%)
$2.88 M(-12.7%)
Apr 2015
$3.29 M(-34.7%)
-$70.70 K(-107.2%)
$3.29 M(-55.0%)
Jan 2015
-
$978.60 K(-7.4%)
$7.32 M(+5.6%)
Oct 2014
-
$1.06 M(-20.5%)
$6.93 M(+12.1%)
Jul 2014
-
$1.33 M(-66.3%)
$6.18 M(+22.4%)
Apr 2014
$5.05 M
$3.95 M(+571.5%)
$5.05 M(+278.7%)
DateAnnualQuarterlyTTM
Jan 2014
-
$588.30 K(+90.8%)
$1.33 M(+37.3%)
Oct 2013
-
$308.40 K(+55.3%)
$970.20 K(+15.1%)
Jul 2013
-
$198.60 K(-16.2%)
$842.60 K(-16.4%)
Apr 2013
$1.01 M(+20.7%)
$236.90 K(+4.7%)
$1.01 M(-10.7%)
Jan 2013
-
$226.30 K(+25.2%)
$1.13 M(+20.8%)
Oct 2012
-
$180.80 K(-50.4%)
$934.60 K(-20.2%)
Jul 2012
-
$364.20 K(+1.7%)
$1.17 M(-20.0%)
Apr 2012
$835.50 K(+73.2%)
$358.00 K(+1032.9%)
$1.46 M(+6.2%)
Jan 2012
-
$31.60 K(-92.4%)
$1.38 M(-3.3%)
Oct 2011
-
$417.50 K(-36.4%)
$1.42 M(+37.1%)
Jul 2011
-
$656.70 K(+141.5%)
$1.04 M(+115.6%)
Apr 2011
$482.30 K(-70.8%)
$271.90 K(+245.1%)
$482.30 K(+7.6%)
Jan 2011
-
$78.80 K(+144.7%)
$448.10 K(-54.6%)
Oct 2010
-
$32.20 K(-67.6%)
$988.00 K(-21.6%)
Jul 2010
-
$99.40 K(-58.2%)
$1.26 M(-23.6%)
Apr 2010
$1.65 M(-72.2%)
$237.70 K(-61.6%)
$1.65 M(-67.6%)
Jan 2010
-
$618.70 K(+102.9%)
$5.09 M(-6.7%)
Oct 2009
-
$305.00 K(-37.7%)
$5.45 M(-4.1%)
Jul 2009
-
$489.40 K(-86.7%)
$5.69 M(-3.5%)
Apr 2009
$5.93 M(+39.2%)
$3.67 M(+274.4%)
$5.89 M(+69.4%)
Jan 2009
-
$981.60 K(+81.6%)
$3.48 M(-4.6%)
Oct 2008
-
$540.60 K(-22.3%)
$3.65 M(-5.1%)
Jul 2008
-
$696.00 K(-44.8%)
$3.84 M(-9.8%)
Apr 2008
$4.26 M(-4.7%)
$1.26 M(+9.7%)
$4.26 M(-1.0%)
Jan 2008
-
$1.15 M(+55.9%)
$4.30 M(+8.7%)
Oct 2007
-
$737.60 K(-33.6%)
$3.96 M(-1.2%)
Jul 2007
-
$1.11 M(-14.7%)
$4.00 M(-10.7%)
Apr 2007
$4.47 M(-42.3%)
$1.30 M(+62.0%)
$4.48 M(-49.6%)
Jan 2007
-
$804.00 K(+2.6%)
$8.90 M(-0.0%)
Oct 2006
-
$784.00 K(-50.8%)
$8.90 M(+7.8%)
Jul 2006
-
$1.59 M(-72.1%)
$8.25 M(+6.4%)
Apr 2006
$7.75 M(+350.1%)
$5.71 M(+609.4%)
$7.75 M(+116.4%)
Jan 2006
-
$805.60 K(+475.0%)
$3.58 M(+26.6%)
Oct 2005
-
$140.10 K(-87.2%)
$2.83 M(+2.3%)
Jul 2005
-
$1.09 M(-29.3%)
$2.77 M(+39.8%)
Apr 2005
$1.72 M(+429.7%)
$1.54 M(+2819.1%)
$1.98 M(+184.1%)
Jan 2005
-
$52.90 K(-30.9%)
$696.50 K(+2.5%)
Oct 2004
-
$76.60 K(-74.9%)
$679.50 K(+10.0%)
Jul 2004
-
$305.30 K(+16.7%)
$617.60 K(+89.9%)
Apr 2004
$325.20 K(+913.1%)
$261.70 K(+629.0%)
$325.20 K(+412.1%)
Jan 2004
-
$35.90 K(+144.2%)
$63.50 K(+130.1%)
Oct 2003
-
$14.70 K(+14.0%)
$27.60 K(+114.0%)
Jul 2003
-
$12.90 K
$12.90 K
Apr 2003
$32.10 K
-
-

FAQ

  • What is PharmaCyte Biotech annual SGA?
  • What is the all time high annual SGA for PharmaCyte Biotech?
  • What is PharmaCyte Biotech annual SGA year-on-year change?
  • What is PharmaCyte Biotech quarterly SGA?
  • What is the all time high quarterly SGA for PharmaCyte Biotech?
  • What is PharmaCyte Biotech quarterly SGA year-on-year change?
  • What is PharmaCyte Biotech TTM SGA?
  • What is the all time high TTM SGA for PharmaCyte Biotech?
  • What is PharmaCyte Biotech TTM SGA year-on-year change?

What is PharmaCyte Biotech annual SGA?

The current annual SGA of PMCB is $4.79 M

What is the all time high annual SGA for PharmaCyte Biotech?

PharmaCyte Biotech all-time high annual SGA is $7.75 M

What is PharmaCyte Biotech annual SGA year-on-year change?

Over the past year, PMCB annual SGA has changed by +$38.20 K (+0.80%)

What is PharmaCyte Biotech quarterly SGA?

The current quarterly SGA of PMCB is $725.30 K

What is the all time high quarterly SGA for PharmaCyte Biotech?

PharmaCyte Biotech all-time high quarterly SGA is $5.71 M

What is PharmaCyte Biotech quarterly SGA year-on-year change?

Over the past year, PMCB quarterly SGA has changed by -$373.00 K (-33.96%)

What is PharmaCyte Biotech TTM SGA?

The current TTM SGA of PMCB is -$418.47 M

What is the all time high TTM SGA for PharmaCyte Biotech?

PharmaCyte Biotech all-time high TTM SGA is -$643.30 K

What is PharmaCyte Biotech TTM SGA year-on-year change?

Over the past year, PMCB TTM SGA has changed by -$423.12 M (-9104.85%)